Dominique Nochy
Overview
Explore the profile of Dominique Nochy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rousselin C, Amoura Z, Faguer S, Bataille P, Boffa J, Canaud G, et al.
J Autoimmun
. 2022 Aug;
132:102889.
PMID: 35987174
Background: Antiphospholipid syndrome (APS) nephropathy (APSN) is a rare pattern with specific features resulting from microvascular lesions. The prognosis of APSN, outside of lupus nephritis, is unknown. The aim of...
2.
Nezam D, Porcher R, Grolleau F, Morel P, Titeca-Beauport D, Faguer S, et al.
J Am Soc Nephrol
. 2022 Jan;
33(3):628-637.
PMID: 35074934
Background: Data from the PEXIVAS trial challenged the role of plasma exchange (PLEX) in ANCA-associated vasculitides (AAV). We aimed to describe kidney biopsy from patients with AAV treated with PLEX,...
3.
Cohen C, Le Goff O, Soysouvanh F, Vasseur F, Tanou M, Nguyen C, et al.
EMBO Mol Med
. 2021 Nov;
13(11):e14146.
PMID: 34725920
The mechanisms underlying the development of glomerular lesions during aging are largely unknown. It has been suggested that senescence might play a role, but the pathophysiological link between senescence and...
4.
Ensergueix G, Pallet N, Joly D, Levi C, Chauvet S, Trivin C, et al.
Clin Kidney J
. 2020 Sep;
13(4):660-665.
PMID: 32897279
Background: Ifosfamide, a widely prescribed antineoplasic agent, is frequently associated with kidney dysfunction. Its nephrotoxicity is well documented in children, but data are lacking in adult patients. Methods: The aim...
5.
Meyer L, Ulrich M, Ducloux D, Garrigue V, Vigneau C, Nochy D, et al.
Am J Kidney Dis
. 2020 Jul;
76(3):384-391.
PMID: 32660897
Rationale & Objective: Fibrinogen A α-chain amyloidosis (AFib amyloidosis) is a form of amyloidosis resulting from mutations in the fibrinogen A α-chain gene (FGA), causing progressive kidney disease leading to...
6.
Miquelestorena-Standley E, Jaulerry C, Machet M, Rabot N, Barbet C, Hummel A, et al.
Diagn Pathol
. 2020 May;
15(1):62.
PMID: 32460869
Background: Infection-related glomerulonephritis with IgA deposits (IRGN-IgA) is a rare disease but it is increasingly reported in the literature. Data regarding epidemiology and outcome are lacking, especially in Europe. We...
7.
Dion J, Maisonobe T, Nochy D, Le Jeunne C, Regent A
J Clin Rheumatol
. 2020 Apr;
27(7):e256-e257.
PMID: 32345843
No abstract available.
8.
Lazareth H, Henique C, Lenoir O, Puelles V, Flamant M, Bollee G, et al.
Nat Commun
. 2019 Jul;
10(1):3303.
PMID: 31341160
The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) remain poorly understood. A key question is how parietal epithelial cells (PECs) invade...
9.
Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, et al.
Blood
. 2018 Dec;
133(6):576-587.
PMID: 30578255
Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of B-cell clonal disorders, defined by Congo red negative-deposits of monoclonal light chain (LCDD), heavy chain (HCDD), or both (LHCDD). MIDD...
10.
Henique C, Bollee G, Loyer X, Grahammer F, Dhaun N, Camus M, et al.
Nat Commun
. 2017 Nov;
8(1):1829.
PMID: 29184126
Crescentic rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of acquired glomerular disease. While most therapeutic approaches involve potentially toxic immunosuppressive strategies, the pathophysiology remains incompletely understood. Podocytes are...